EGA
FBIO icon

Eagle Global Advisors’s Fortress Biotech FBIO Stock Holding History

Eagle Global Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,096
Closed -$88K – 376
2015
Q4 		$88K Sell
2,096
-2,002
-49% -$83.9K ﹤0.01% 354
2015
Q3 		$160K Sell
4,098
-3,375
-45% -$158K 0.01% 333
2015
Q2 		$377K Buy
7,473
+3,870
+107% +$199K 0.01% 255
2015
Q1 		$208K Buy
+3,603
New +$150K 0.01% 309

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Eagle Global Advisors's FBIO Position: Q1 2016 in Review

Eagle Global Advisors sold out of Fortress Biotech (FBIO) in Q1 2016, closing a stake of 2,096 shares — an estimated $88K sold.

Eagle Global Advisors first reported a position in FBIO in Q1 2015 and held it in 4 quarters. The position peaked at $377K in Q2 2015. 44 funds tracked by Wall St. Rank hold FBIO as of Q1 2016.

  • Eagle Global Advisors reported no remaining Fortress Biotech position as of Q1 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 2,096 Fortress Biotech shares in Q1 2016, an estimated $88K.
  • Eagle Global Advisors first reported a position in Fortress Biotech in Q1 2015 and held it in 4 quarters.
  • Eagle Global Advisors's Fortress Biotech position peaked at $377K in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2016.

Based on Eagle Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.